Moderna shows early evidence of mRNA-encoded antibody production at R&D day

Moderna unveiled the first clinical evidence of mRNA-encoded mAb production during its R&D day, which featured Phase I data for its chikungunya therapy and CMV vaccine.

No approved vaccines or therapies exist for chikungunya, a tropical mosquito-borne viral infection. And

Read the full 392 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE